Ginkgo Bioworks Holdings (DNA) Gross Profit (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has 7 years of Gross Profit data on file, last reported at $16.4 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit fell 52.03% year-over-year to $16.4 million; the trailing twelve-month figure through Mar 2026 stood at $150.2 million (down 38.01% YoY), and the FY2025 full-year result was $170.2 million, down 25.06% from the prior year.
• Gross Profit for Q1 2026 stood at $16.4 million, down from $59.0 million in the prior quarter.
• Across five years, Gross Profit topped out at $82.1 million in Q4 2023 and bottomed at -$91.7 million in Q2 2023.
• The 5-year median for Gross Profit is $34.1 million (2025), against an average of $23.6 million.
• The widest annual swing landed in 2022, when Gross Profit plunged 622.68%; it then soared 15212.15% in 2023.
• A 5-year view of Gross Profit shows it stood at $550000.0 in 2022, then soared by 14836.18% to $82.1 million in 2023, then declined by 8.89% to $74.8 million in 2024, then declined by 21.21% to $59.0 million in 2025, then sank by 72.23% to $16.4 million in 2026.
• The last three Gross Profit figures came in at $16.4 million (Q1 2026), $59.0 million (Q4 2025), and $30.7 million (Q3 2025), per Business Quant data.

Peer Comparison